Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Dual GIP & GLP-1 Receptor Agonist
Tirzepatide is a synthetic peptide that acts on two metabolic signaling pathways: GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors.
It is widely studied for its effects on metabolic signaling, glucose regulation, insulin response, energy balance, appetite signaling, and lipid metabolism.
Dual GIP & GLP-1 Receptor Agonist
Tirzepatide is a synthetic peptide that acts on two metabolic signaling pathways: GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors.
It is widely studied for its effects on metabolic signaling, glucose regulation, insulin response, energy balance, appetite signaling, and lipid metabolism.